Manufacturers/Tris Pharma Inc

Tris Pharma Inc

16 drugs in NADAC|16 Generic,0 Brand

View Recalls (8)

Tris Pharma Inc lists 16 NDCs in the CMS NADAC file (16 generic, 0 brand), at an average NADAC of $0.37 per unit, with a week-over-week move of -5.9% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

16

16G / 0B

Avg Price / Unit

$0.3734

$0.05 – $1.24

Avg 7d Change

-5.92%

Across 6 drugs with changes

7d Activity

1510 flat

of 16 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Tris Pharma Inc make?

Tris Pharma Inc lists 16 NDCs in the CMS NADAC file — 16 generic and 0 brand products.

What is the average price of Tris Pharma Inc drugs?

The average NADAC across Tris Pharma Inc's portfolio is $0.3734 per unit, ranging from $0.0535 to $1.2437.

What types of drugs does Tris Pharma Inc make?

Tris Pharma Inc makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Atypical Antipsychotic (4), Xanthine Oxidase Inhibitor (2).

Has Tris Pharma Inc had any drug recalls?

8 FDA recalls are matched to Tris Pharma Inc in the openFDA feed, most recently on Jul 11, 2019.

How has Tris Pharma Inc's pricing changed recently?

Over the past 7 days, 1 Tris Pharma Inc product rose and 5 fell, with a portfolio-wide average change of -5.9%.

Drug Portfolio

16 drugs total, 16 shown

Drug Price 7d Change
PALIPERIDONE ER 9 MG TABLET
paliperidone
$1.2437
per EA
-3.73%
PALIPERIDONE ER 6 MG TABLET
paliperidone
$1.0912
per EA
-4.56%
PALIPERIDONE ER 3 MG TABLET
paliperidone
$0.9527
per EA
-9.43%
PALIPERIDONE ER 1.5 MG TABLET
paliperidone
$0.7658
per EA
-11.58%
FEBUXOSTAT 80 MG TABLET
febuxostat
$0.3297
per EA
-6.75%
LACOSAMIDE 200 MG TABLET
Lacosamide
$0.3159
per EA
LACOSAMIDE 150 MG TABLET
Lacosamide
$0.2856
per EA
LACOSAMIDE 100 MG TABLET
Lacosamide
$0.2451
per EA
FEBUXOSTAT 40 MG TABLET
febuxostat
$0.2128
per EA
+0.54%
LACOSAMIDE 50 MG TABLET
Lacosamide
$0.1487
per EA
PREGABALIN 300 MG CAPSULE
Pregabalin
$0.0772
per EA
PREGABALIN 200 MG CAPSULE
Pregabalin
$0.0661
per EA
PREGABALIN 150 MG CAPSULE
Pregabalin
$0.0641
per EA
PREGABALIN 100 MG CAPSULE
Pregabalin
$0.0609
per EA
PREGABALIN 75 MG CAPSULE
Pregabalin
$0.0604
per EA
PREGABALIN 50 MG CAPSULE
Pregabalin
$0.0535
per EA

FDA Recalls (8)

Recalls matched by company name. Verify current status with FDA.

D-1517-2019
Terminated
Class II

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.

Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

Initiated: 7/11/2019
D-0495-2019
Terminated
Class II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39961 3, NDC 50428-1252-4.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Initiated: 1/15/2019
D-0493-2019
Terminated
Class II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Initiated: 1/15/2019
D-0494-2019
Terminated
Class II

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Initiated: 1/15/2019
D-0337-2019
Terminated
Class II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Initiated: 11/26/2018
D-0336-2019
Terminated
Class II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Free Non-Staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Family Dollar Services, Inc., 10301 Monroe Road, Matthews, NC 28105, NDC 55319-250-23, UPC 0 32251 03374 2.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Initiated: 11/26/2018
D-0335-2019
Terminated
Class II

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23, UPC 0 78742 02016 7.

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Initiated: 11/26/2018
D-1126-2017
Terminated
Class II

Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL with an oral syringe, Rx Only, Manufactured by: Tris Pharma, Inc. Monmouth Junction, NJ 08852, NDC 27808-082-01

Defective container: Oral solution leaking from container.

Initiated: 6/15/2017